Cielo Velandia Kellner, FNP-C

Cielo Velandia Kellner practices at Dermatology and Plastic Surgery Associates, S.C. in Bourbonnais, Illinois.

Cielo Velandia Kellner's NPI, 1770192080, was assigned on July 23, 2020. Cielo Velandia Kellner holds Illinois license 209021625.

Cielo Velandia Kellner's primary practice is Dermatology and Plastic Surgery Associates, S.C., at 595 William Latham Dr, Bourbonnais, IL 60914 in Kankakee County. The practice phone is (815) 744-8554.

Cielo Velandia Kellner's primary practice is Dermatology and Plastic Surgery Associates, S.C. in Bourbonnais, Illinois. The medical group on file is Pinnacle Dermatology. Dmand AI also links Cielo Velandia Kellner to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cielo Velandia Kellner practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Cielo Velandia Kellner's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Cielo Velandia Kellner is licensed in Illinois.

CMS counts 67 Medicare patients who saw Cielo Velandia Kellner in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Cielo Velandia Kellner's median patient age at 56, with 61% women.

In 2024, Cielo Velandia Kellner wrote 87 Medicare Part D claims for 33 patients. 89% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Cielo Velandia Kellner for performance year 2024, reported as part of a group. Cielo Velandia Kellner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Cielo Velandia Kellner from 9 drug and device companies in 2025. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $309.